Noboru Oishi
About
In The Last Decade
Noboru Oishi
45 papers receiving 759 citations
Peers
Comparison fields: 5 of 104
- Oncology 306
- Pulmonary and Respiratory Medicine 184
- Molecular Biology 180
- Surgery 150
- Genetics 99
Countries citing papers authored by Noboru Oishi
This map shows the geographic impact of Noboru Oishi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noboru Oishi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noboru Oishi more than expected).
Fields of papers citing papers by Noboru Oishi
This network shows the impact of papers produced by Noboru Oishi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noboru Oishi. The network helps show where Noboru Oishi may publish in the future.
Co-authorship network of co-authors of Noboru Oishi
This figure shows the co-authorship network connecting the top 25 collaborators of Noboru Oishi. A scholar is included among the top collaborators of Noboru Oishi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noboru Oishi. Noboru Oishi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 63 | |
| 3 | 15 | |
| 4 | 11 | |
| 5 | 2 | |
| 6 | 21 | |
| 7 | 3 | |
| 8 | 21 | |
| 9 | 2 | |
| 10 | 8 | |
| 11 | 3 | |
| 12 | 14 | |
| 13 | 1 | |
| 14 | Phase II trial of amsacrine in metastatic or locally recurrent squamous cell carcinoma from head and neck primaries: a Southwest Oncology Group study. | 2 |
| 15 | Randomized trial of hexamethylmelamine versus 5-FU, doxorubicin, and cyclophosphamide (FAC) in advanced transitional cell bladder carcinoma: a Southwest Oncology Group study. | 9 |
| 16 | Phase II trial of amsacrine in pancreatic carcinoma: a Southwest Oncology Group study. | 2 |
| 17 | 154 | |
| 18 | 3 | |
| 19 | Studies on ADP-induced platelet aggregation in normal and diseased groups. | 3 |
| 20 | 38 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.